Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)

Summary

The purpose of this study is to determine the safe and tolerable, biologically active, and potentially effective doses(s) of ALD518 in subjects with acute GVHD, who have failed to respond to glucocorticosteroids, for further investigation in Part B.

Timeline

Start

2012-03

Primary completion

2013-03

Completion

2013-03

Outcome

Outcome not reported

Stopped: “The trial was terminated in line with the endpoint committee charter.”

Drugs

Indications